The Bill Kelly Show Podcast:
Canadian drug developer Medicago said on Tuesday it had started a late-stage study of its experimental COVID-19 vaccine combined with a booster from GlaxoSmithKline.
The study plans to eventually enroll 30,000 participants and initially focus on healthy adults, followed by adults over the age of 65 and those with co-morbidities.
Medicago, which has Canada’s most advanced COVID-19 vaccine project under development, expects to report results from a mid-stage trial of the vaccine in April.
GUEST: Brian Ward, Medical Officer with Medicago
-
Ontario's long-term care homes are losing staff to places like Amazon, aiports and the film industry.
According to the Ontario Long-Term Care Association, the staffing crisis is worsening now that other industries need people like infection prevention and control specialists.
Staffing shortages have been cited as one of the main reasons the pandemic has had such devastating effects in nursing homes.
GUEST: Donna Duncan, CEO of the Ontario Long Term Care Association
-
Canada has indeed asked the United States for help in procuring doses of COVID-19 vaccines, but the White House refused to say Wednesday whether it has agreed to the request.
Press secretary Jen Psaki will only say that the Biden administration is considering the request, not whether it has agreed to it.
ALSO: EU proposes coronavirus passes to allow people to travel freely in region by summer
GUEST: Elliot Tepper, Emeritus Professor of Political science, Carleton University
See omnystudio.com/listener for privacy information.